Neuroscience
Neurotransmitter receptors function via various G-protein coupled and G-protein independent mechanisms that activate downstream intracellular signaling pathways such as cAMP/PKA, PI3K/AKT, phospholipase A2, and phospholipase C pathways. For instance, dopamine receptors act through adenylate cyclase to activate PKA and other signaling molecules, thereby mediate gene expression through the actions of CREB and other transcription factors. Other neurotransmitters such as NMDAR or AMPAR are associated with ion channels that control flux of Ca2+ and Na+, thus propagating the action potential across the post-synaptic neuron.
Dysfunctions in GABAergic/glutamatergic/serotonergic/dopaminergic pathways result in a broad range of neurological disorders such as chronic pain, neurodegenerative diseases, and insomnia, as well as mental disorders including schizophrenia, bipolar disorder, depression, and addiction.
- B7549 CBiPES hydrochlorideSummary: positive allosteric modulator of the mGlu2 receptor
- B7565 L 760735Summary: NK1 receptor antagonist
- B7567 JNJ 10181457 dihydrochlorideSummary: Histamine H3 receptor antagonist
- B7575 BINASummary: mGlu2 positive allosteric modulator
- B7585 PE 154Summary: human acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) inhibitor
- B7592 Cinnabarinic acidSummary: mGlu4 receptor agonist
- B7597 LY 2087101Summary: Allosteric potentiator of α7, α4β2 and α4β4 nAChRs
- B7607 SonepiprazoleSummary: rat and human dopamine D4 receptor antagonist
- B7624 TQSSummary: positive allosteric modulator of α7 nACh receptors
- B7629 TCN 238Summary: Positive allosteric modulator of mGlu4 receptors